DrugPatentWatch Database Preview
Biovitrum Ab Company Profile
Summary for Biovitrum Ab
| Patents: | 142 |
| Tradenames: | 2 |
| Ingredients: | 2 |
| BLAs: | 2 |
US Patents for Biovitrum Ab
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Number | Approval Date | Patent No. | Assignee | Estimated Patent Expiration | Status | Orphan | Source |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Biovitrum Ab | KINERET | anakinra | VIAL; SUBCUTANEOUS | 103950 | 001 | 2001-11-14 | 10,016,338 | SIO2 MEDICAL PRODUCTS, INC. (Auburn, AL) | 2033-03-11 | RX | search | |
| Biovitrum Ab | KINERET | anakinra | VIAL; SUBCUTANEOUS | 103950 | 001 | 2001-11-14 | 10,023,841 | Baylor Research Institute (Dallas, TX) | 2034-05-23 | RX | search | |
| Biovitrum Ab | KINERET | anakinra | VIAL; SUBCUTANEOUS | 103950 | 001 | 2001-11-14 | 10,081,657 | TECHNISCHE UNIVERSITAT MUNCHEN (Munich, DE) XL-PROTEIN GMBH (Freising, DE) | 2030-05-21 | RX | search | |
| Biovitrum Ab | KINERET | anakinra | VIAL; SUBCUTANEOUS | 103950 | 001 | 2001-11-14 | 10,111,968 | CureVac AG (Tubingen, DE) | 2032-02-15 | RX | search | |
| Biovitrum Ab | KINERET | anakinra | VIAL; SUBCUTANEOUS | 103950 | 001 | 2001-11-14 | 10,124,038 | ORBSEN THERAPEUTICS LIMITED (Galway, IE) | 2035-03-20 | RX | search | |
| Biovitrum Ab | KINERET | anakinra | VIAL; SUBCUTANEOUS | 103950 | 001 | 2001-11-14 | 10,179,162 | SWEDISH ORPHAN BIOVITRUM AB (PUBL) (Stockholm, SE) | 2031-02-11 | RX | search | |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Number | >Approval Date | >Patent No. | >Assignee | >Estimated Patent Expiration | >Status | >Orphan | >Source |
